Tiffany P. Quock, PhD, MS is an epidemiologist and health economist by training, with nearly 20 years of experience in HEOR, RWE, and Global Value and Access. She is currently the Vice President, Health Economics and Outcomes Research at Crinetics Pharmaceuticals, a San Diego based pharmaceuticals company developing therapies for people with endocrine diseases and endocrine-related disorders. Previously, Dr. Quock was the Head of Global Health Economics and Outcomes Research, and Head of Medical Affairs at Prothena Biosciences, where she had worked in Zug, Switzerland to support the European launch. She has experience across a multitude of therapeutic areas, including rare diseases, neuroscience, oncology/hematology, and inflammatory conditions. Dr. Quock started her career as a Visiting Assistant Professor and Researcher at UCLA, David Geffen School of Medicine, where she taught research methods to graduate students and RWJF Health Policy Fellows. During her time at UCLA, she conducted research on breast cancer and neurodegenerative diseases. She has also worked at Amgen, ICON plc, and Jazz Pharmaceuticals with increasing responsibilities, leading teams as well as designing evidence throughout the entire product lifecycle to support approval and market access.

Dr. Quock has expertise identifying appropriate PRO endpoints for clinical trials, developing and validating de novo PRO instruments in rare diseases, designing RWE studies and economic models to frame value propositions, and developing compelling evidence for negotiations with HTA agencies. She received her PhD and MS in Health Services Research, with Cognates in Health Care Outcomes Research and Epidemiology at UCLA. In addition, Dr. Quock completed fellowships in Cancer Control at UCSF, Economics and Epidemiology at Pardee RAND Graduate School, and Entrepreneurship at Stanford University Graduate School of Business.